Business Description
Devonian Health Group Inc
NAICS : 325410
SIC : 3741
ISIN : CA2518341078
Share Class Description:
DVHGF: Ordinary Shares - NewTotal Employee Number:
8Description
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 8.18 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.91 | |||||
Beneish M-Score | -0.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 101.8 | |||||
3-Year EBITDA Growth Rate | -35.4 | |||||
3-Year EPS without NRI Growth Rate | 25.5 | |||||
3-Year FCF Growth Rate | 29.9 | |||||
3-Year Book Growth Rate | -20.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 0.01 | |||||
14-Day RSI | 0.37 | |||||
6-1 Month Momentum % | 149.65 | |||||
12-1 Month Momentum % | -1.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.56 | |||||
Quick Ratio | 1.55 | |||||
Cash Ratio | 0.81 | |||||
Days Inventory | 3 | |||||
Days Sales Outstanding | 100.44 | |||||
Days Payable | 239.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.2 | |||||
Shareholder Yield % | -1.72 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 44.51 | |||||
Operating Margin % | -42.07 | |||||
Net Margin % | -88.16 | |||||
EBITDA Margin % | -38.94 | |||||
FCF Margin % | -96.3 | |||||
OCF Margin % | -96.3 | |||||
ROE % | -91.39 | |||||
ROA % | -48.48 | |||||
ROIC % | -52.38 | |||||
3-Year ROIIC % | -31.96 | |||||
ROC (Joel Greenblatt) % | -187.92 | |||||
ROCE % | -42.5 | |||||
Moat Score | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.28 | |||||
PB Ratio | 3.24 | |||||
Price-to-Tangible-Book | 8.54 | |||||
EV-to-EBIT | -5.84 | |||||
EV-to-EBITDA | -6.2 | |||||
EV-to-Revenue | 2.41 | |||||
EV-to-FCF | -2.54 | |||||
Price-to-GF-Value | 2.32 | |||||
| Price-to-Net-Current-Asset-Value | 31.82 | |||||
Earnings Yield (Greenblatt) % | -17.12 | |||||
FCF Yield % | -37.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:DVHGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Devonian Health Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 7.306 | ||
| EPS (TTM) ($) | -2.305 | ||
| Beta | -0.831 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 0.78 | ||
| Volatility % | 80.41 | ||
| 14-Day RSI | 0.37 | ||
| 14-Day ATR ($) | 0.155772 | ||
| 20-Day SMA ($) | 9.19 | ||
| 12-1 Month Momentum % | -1.39 | ||
| 52-Week Range ($) | 4.265999 - 10.799999 | ||
| Shares Outstanding (Mil) | 2.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Devonian Health Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Devonian Health Group Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.0166667:1 Stock Split | 2026-01-22 | 4.27 (+0.00%) |
Show
Entries
Devonian Health Group Inc Frequently Asked Questions
What is Devonian Health Group Inc(DVHGF)'s stock price today?
The current price of DVHGF is $7.00. The 52 week high of DVHGF is $10.80 and 52 week low is $4.27.
When is next earnings date of Devonian Health Group Inc(DVHGF)?
The next earnings date of Devonian Health Group Inc(DVHGF) is .
Does Devonian Health Group Inc(DVHGF) pay dividends? If so, how much?
Devonian Health Group Inc(DVHGF) does not pay dividend.
Guru Commentaries on OTCPK:DVHGF
No articles.
Press Release
Articles on Devonian Health Group Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers